Search results
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 4 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 16 hours agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday, Benzinga reports ...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 8 hours agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Weight loss drugs Wegovy and Mounjaro could spawn a host of new piggyback product lines
CNBC· 14 hours agoNovo Nordisk's Wegovy weight loss drug has seen a meteoric rise in popularity. LONDON — The rapid...
Lawsuits pile up over state laws on discounts for hospitals' contract pharmacies
Reuters· 4 days agoThe pharmaceutical industry has filed at least four lawsuits this year challenging state laws...
Stakeholders question federal drug discount program at Michigan House Insurance hearing
Michigan Advance via Yahoo News· 1 day agoWhile the House Insurance and Financial Services Committee only had one item on its agenda on...
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential - Novo...
Benzinga· 5 hours agoThe Roundhill GLP-1 Weight Loss ETF OZEM and the Amplify Weight Loss Drug and Treatment ETF THNR...
Paxlovid Fails to Quell Long Covid Symptoms in Stanford Study
Bloomberg· 39 minutes agoA 15-day course of Pfizer Inc.’s antiviral Paxlovid didn’t provide significant relief for long Covid patients, researchers at Stanford University found.
Meet the anti-abortion group using white coats and research to advance its cause
NBC News via Yahoo News· 2 hours agoThe Supreme Court will soon rule on mifepristone. It opted not to hear arguments challenging the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 hour agoNotably, some companies are fighting back against plans for Medicare to begin negotiating the prices...